tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
VYNE
VYNE Therapeutics
RESEARCH TOOLSreports
Want to see VYNE full AI Analyst Report?

VYNE Therapeutics (VYNE) Income Statement

1,903 Followers

VYNE Therapeutics Income Statement

Last quarter (Q4 2025), VYNE Therapeutics's total revenue was $130.00K, an increase of 54.76% from the same quarter last year. In Q4, VYNE Therapeutics's net income was $-4.84M. See VYNE Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 570.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
Gross Profit
$ 547.00K$ 501.00K$ 424.00K$ 477.00K$ 931.00K
Operating Expenses
$ 30.30M$ 44.14M$ 29.68M$ 34.77M$ 39.84M
Depreciation and Amortization
$ 0.00$ 4.00K$ 0.00$ 72.00K$ 109.00K
EBITDA
$ -26.73M$ -43.63M$ -29.26M$ -34.22M$ -38.80M
Operating Income
$ -29.75M$ -43.64M$ -29.26M$ -34.30M$ -38.91M
Other Income/Expenses
$ 3.02M$ 3.83M$ 1.39M$ 363.00K$ -4.85M
Pretax Income
$ -26.73M$ -39.80M$ -27.87M$ -33.93M$ -43.76M
Net Income
$ -26.48M$ -39.83M$ -28.45M$ -23.21M$ -73.33M
Per Share Metrics
Basic EPS
$ -0.62$ -0.93$ -2.77$ -10.65$ -25.65
Diluted EPS
$ -0.62$ -0.93$ -2.77$ -10.65$ -25.65
Weighted Average Shares Outstanding
 42.77M 42.59M 10.27M 3.19M 2.86M
Weighted Average Shares Outstanding (Diluted)
 42.77M 42.59M 10.27M 3.19M 2.86M
Currency in USD

VYNE Therapeutics Earnings and Revenue History